Characterization of Antibody Drug Conjugates (ADC) using 2-Dimension Liquid Chromatography (2D-LC) and Native Mass Spectrometric Technologies

Posters | 2021 | Agilent Technologies | ASMSInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
2026|Agilent Technologies|Brochures and specificationsApplications
Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods
Drug to Antibody Ratio Analysis of Brentuximab Vedotin in Monkey Plasma